1-Methyl-1,2,3,4-Tetrahydroisoquinoline: A Potent Neuroprotecting Agent

作者: Jerzy Vetulani , Lucyna Antkiewicz-Michaluk

DOI: 10.1007/978-1-4614-1542-8_3

关键词:

摘要: 1-Methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), unlike several other tetrahydroisoquinolines, displays neuroprotective properties. To elucidate this action we compared the effects of 1MeTIQ with 1,2,3,4-tetrahydroisoquinoline (TIQ), a compound sharing many activities (e.g., reducing free radicals formed during dopamine catabolism) but offering no clear neuroprotection. We found that compounds similarly inhibit radical generation in an abiotic system, as well indices neurotoxicity, caspase-3 activity, and lactate dehydrogenase release induced by glutamate mouse embryonic primary cell cultures. also prevents glutamate-induced death 45Ca2+ influx, whereas TIQ did not. In vivo microdialysis study has shown kainate-induced excitatory amino acids from rat frontal cortex. Additionally, protects against rotenone-induced mortality, oxidative stress dopaminergic neurodegeneration extrapyramidal structures produced intracerebral injection rotenone. The results suggest offers unique complex mechanism neuroprotection which scavenging properties inhibition excitotoxicity may play very important role, indicates potential therapeutic agent various neurodegenerative illnesses central nervous system.

参考文章(76)
Ulrike Thull, Silvia Kneubühler, Patrick Gaillard, Pierre-Alain Carrupt, Bernard Testa, Cosimo Altomare, Angelo Carotti, Peter Jenner, Kevin St. P. McNaught, Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships. Biochemical Pharmacology. ,vol. 50, pp. 869- 877 ,(1995) , 10.1016/0006-2952(95)00220-T
James A. Dykens, Free Radicals and Mitochondria Dysfunction in Excitotoxicity and Neurodegenerative Disease Cell Death and Diseases of the Nervous System. pp. 45- 68 ,(1999) , 10.1007/978-1-4612-1602-5_3
C D Marsden, P Jenner, The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Journal of Neural Transmission-supplement. ,vol. 20, pp. 11- 39 ,(1986)
Zaniewska M, Antkiewicz-Michaluk L, Przegaliński E, Filip M, Frankowska M, Gołda A, Vetulani J, Effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the behavioral effects of cocaine in rats. Journal of Physiology and Pharmacology. ,vol. 58, pp. 625- 639 ,(2007)
Lucyna Antkiewicz-Michaluk, Jerzy Michaluk, Maria Mokrosz, Irena Romanska, Elbieta Lorenc-Koci, Shigeru Ohta, Jerzy Vetulani, Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. Journal of Neurochemistry. ,vol. 78, pp. 100- 108 ,(2001) , 10.1046/J.1471-4159.2001.00391.X
Ranjita Betarbet, Todd B. Sherer, Gillian MacKenzie, Monica Garcia-Osuna, Alexander V. Panov, J. Timothy Greenamyre, Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neuroscience. ,vol. 3, pp. 1301- 1306 ,(2000) , 10.1038/81834
Thomas P. Singer, Rona R. Ramsay, Flauoprotein structure and mechanism 2. Monoamine oxidases: old friends hold many surprises. The FASEB Journal. ,vol. 9, pp. 605- 610 ,(1995) , 10.1096/FASEBJ.9.8.7768351
Lucyna Antkiewicz-Michaluk, Jerzy W. Lazarewicz, Antoni Patsenka, Malgorzata Kajta, Elzbieta Zieminska, Elzbieta Salinska, Agnieszka Wasik, Krystyna Golembiowska, Jerzy Vetulani, The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity. Journal of Neurochemistry. ,vol. 97, pp. 846- 856 ,(2006) , 10.1111/J.1471-4159.2006.03756.X